Fulgent Genetics (FLGT) Cash from Operations Growth (1y) (2016 - 2026)
Fulgent Genetics (FLGT) Cash from Operations Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.44 Bn | 209.37 Bn | 8.34 Bn | 51.89% |
| 2 | Danaher | 139.95 Bn | 135.60 Bn | 3.61 Bn | 14.65% |
| 3 | Idexx Laboratories | 46.16 Bn | 45.96 Bn | 779.09 Mn | 86.90% |
| 4 | Agilent Technologies | 39.67 Bn | 37.87 Bn | 990.00 Mn | 25.34% |
| 5 | Iqvia Holdings | 39.29 Bn | 37.21 Bn | 1.44 Bn | 25.96% |
| 6 | Natera | 38.61 Bn | 37.51 Bn | 696.04 Mn | -9.63% |
| 7 | Illumina | 29.99 Bn | 28.82 Bn | 770.00 Mn | -14.10% |
| 8 | Mettler Toledo International | 28.57 Bn | 28.51 Bn | 650.22 Mn | 31.33% |
| 9 | Quest Diagnostics | 26.17 Bn | 25.55 Bn | 1.03 Bn | 9.74% |
| 10 | Fulgent Genetics | 515.29 Mn | 258.26 Mn | 25.68 Mn | 21.26% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 21.26% |
| Mar 31, 2026 | 260.17% |
| Dec 31, 2025 | -412.35% |
| Sep 30, 2025 | 171.62% |
| Jun 30, 2025 | -804.11% |
| Mar 31, 2025 | -160.98% |
| Dec 31, 2024 | 67.53% |
| Sep 30, 2024 | -251.46% |
| Jun 30, 2024 | -55.99% |
| Mar 31, 2024 | 191.89% |
| Dec 31, 2023 | -55.03% |
| Sep 30, 2023 | -50.71% |
| Jun 30, 2023 | -12.48% |
| Mar 31, 2023 | -104.20% |
| Dec 31, 2022 | -56.92% |
| Sep 30, 2022 | -86.35% |
| Jun 30, 2022 | -85.38% |
| Mar 31, 2022 | -19.20% |
| Dec 31, 2021 | -42.58% |
| Sep 30, 2021 | 1,516.58% |